DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) Stock Competitors & Peer Comparison
See DHAIW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DHAIW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DHAIW | $0.01 | +225.81% | 21.1K | N/A | N/A | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.51 | -1.89% | 174B | 19.30 | $5.21 | +2.54% |
| MDT | $93.03 | -1.69% | 119B | 16.82 | $5.53 | +3.08% |
| SYK | $297.60 | -2.23% | 114.1B | 22.22 | $13.39 | +1.19% |
| BSX | $44.51 | -2.35% | 64.5B | 14.36 | $3.10 | N/A |
| EW | $88.40 | +0.12% | 50.9B | 32.74 | $2.70 | N/A |
| GEHC | $69.01 | -1.74% | 31.2B | 15.13 | $4.56 | +0.20% |
| DXCM | $80.26 | -6.39% | 30.3B | 31.47 | $2.55 | N/A |
| PHG | $26.23 | +0.88% | 25.6B | 14.99 | $1.75 | +3.78% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
DHAIW vs BSX-PA Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, DHAIW's ROE is +0.25%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, DHAIW is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
DHAIW vs ABT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ABT has a market cap of 174B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ABT trades at $100.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ABT's P/E ratio is 19.30. In terms of profitability, DHAIW's ROE is +0.25%, compared to ABT's ROE of +0.11%. Regarding short-term risk, DHAIW is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ABT's competition here
Medtronic Plc (NYSE: MDT)
DHAIW vs MDT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, MDT has a market cap of 119B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while MDT trades at $93.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas MDT's P/E ratio is 16.82. In terms of profitability, DHAIW's ROE is +0.25%, compared to MDT's ROE of +0.11%. Regarding short-term risk, DHAIW is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
DHAIW vs SYK Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SYK has a market cap of 114.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SYK trades at $297.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SYK's P/E ratio is 22.22. In terms of profitability, DHAIW's ROE is +0.25%, compared to SYK's ROE of +0.16%. Regarding short-term risk, DHAIW is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
DHAIW vs BSX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BSX has a market cap of 64.5B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BSX trades at $44.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BSX's P/E ratio is 14.36. In terms of profitability, DHAIW's ROE is +0.25%, compared to BSX's ROE of +0.15%. Regarding short-term risk, DHAIW is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
DHAIW vs EW Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, EW has a market cap of 50.9B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while EW trades at $88.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas EW's P/E ratio is 32.74. In terms of profitability, DHAIW's ROE is +0.25%, compared to EW's ROE of +0.10%. Regarding short-term risk, DHAIW is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
DHAIW vs GEHC Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, GEHC has a market cap of 31.2B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while GEHC trades at $69.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 15.13. In terms of profitability, DHAIW's ROE is +0.25%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, DHAIW is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check GEHC's competition here
DexCom, Inc. (NASDAQ: DXCM)
DHAIW vs DXCM Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, DXCM has a market cap of 30.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while DXCM trades at $80.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas DXCM's P/E ratio is 31.47. In terms of profitability, DHAIW's ROE is +0.25%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, DHAIW is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check DXCM's competition here
Koninklijke Philips N.V. (NYSE: PHG)
DHAIW vs PHG Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PHG has a market cap of 25.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PHG trades at $26.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PHG's P/E ratio is 14.99. In terms of profitability, DHAIW's ROE is +0.25%, compared to PHG's ROE of +0.10%. Regarding short-term risk, DHAIW is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
DHAIW vs ZBH Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ZBH has a market cap of 18.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ZBH trades at $94.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ZBH's P/E ratio is 11.19. In terms of profitability, DHAIW's ROE is +0.25%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, DHAIW is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
DHAIW vs ABMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ABMD's P/E ratio is 65.36. In terms of profitability, DHAIW's ROE is +0.25%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, DHAIW is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
DHAIW vs PEN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PEN trades at $323.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PEN's P/E ratio is 84.51. In terms of profitability, DHAIW's ROE is +0.25%, compared to PEN's ROE of +0.11%. Regarding short-term risk, DHAIW is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
DHAIW vs SWAV Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SWAV's P/E ratio is 78.76. In terms of profitability, DHAIW's ROE is +0.25%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, DHAIW is less volatile compared to SWAV. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
DHAIW vs SNN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SNN has a market cap of 12.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SNN trades at $29.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SNN's P/E ratio is 19.74. In terms of profitability, DHAIW's ROE is +0.25%, compared to SNN's ROE of +0.12%. Regarding short-term risk, DHAIW is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
DHAIW vs ALGN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ALGN has a market cap of 10.8B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ALGN trades at $151.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ALGN's P/E ratio is 13.80. In terms of profitability, DHAIW's ROE is +0.25%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, DHAIW is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
DHAIW vs GMED Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while GMED trades at $78.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas GMED's P/E ratio is 17.72. In terms of profitability, DHAIW's ROE is +0.25%, compared to GMED's ROE of +0.12%. Regarding short-term risk, DHAIW is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
DHAIW vs GKOS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, GKOS has a market cap of 10.4B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while GKOS trades at $176.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas GKOS's P/E ratio is -205.85. In terms of profitability, DHAIW's ROE is +0.25%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, DHAIW is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
DHAIW vs PODD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PODD trades at $141.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PODD's P/E ratio is 24.17. In terms of profitability, DHAIW's ROE is +0.25%, compared to PODD's ROE of +0.27%. Regarding short-term risk, DHAIW is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
DHAIW vs BIO Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BIO has a market cap of 9.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BIO trades at $360.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BIO's P/E ratio is 38.87. In terms of profitability, DHAIW's ROE is +0.25%, compared to BIO's ROE of +0.03%. Regarding short-term risk, DHAIW is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
DHAIW vs BIO-B Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BIO-B has a market cap of 9.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BIO-B trades at $359.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BIO-B's P/E ratio is -63.39. In terms of profitability, DHAIW's ROE is +0.25%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, DHAIW is similarly volatile compared to BIO-B. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
DHAIW vs MASI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas MASI's P/E ratio is 44.43. In terms of profitability, DHAIW's ROE is +0.25%, compared to MASI's ROE of +0.09%. Regarding short-term risk, DHAIW is similarly volatile compared to MASI. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
DHAIW vs BRKR Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BRKR has a market cap of 9B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BRKR trades at $59.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BRKR's P/E ratio is 29.70. In terms of profitability, DHAIW's ROE is +0.25%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, DHAIW is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
DHAIW vs BRKRP Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BRKRP trades at $430.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BRKRP's P/E ratio is 236.18. In terms of profitability, DHAIW's ROE is +0.25%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, DHAIW is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
DHAIW vs HAE Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, HAE has a market cap of 5.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while HAE trades at $117.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas HAE's P/E ratio is 23.36. In terms of profitability, DHAIW's ROE is +0.25%, compared to HAE's ROE of +0.11%. Regarding short-term risk, DHAIW is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
DHAIW vs NARI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NARI's P/E ratio is -59.24. In terms of profitability, DHAIW's ROE is +0.25%, compared to NARI's ROE of -0.00%. Regarding short-term risk, DHAIW is less volatile compared to NARI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
DHAIW vs LIVN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while LIVN trades at $78.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas LIVN's P/E ratio is 18.63. In terms of profitability, DHAIW's ROE is +0.25%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, DHAIW is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
DHAIW vs ITGR Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ITGR trades at $126.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ITGR's P/E ratio is 19.96. In terms of profitability, DHAIW's ROE is +0.25%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, DHAIW is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
DHAIW vs IRTC Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while IRTC trades at $113.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas IRTC's P/E ratio is -264.07. In terms of profitability, DHAIW's ROE is +0.25%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, DHAIW is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
DHAIW vs NEOG Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NEOG trades at $11.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NEOG's P/E ratio is 42.11. In terms of profitability, DHAIW's ROE is +0.25%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, DHAIW is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
DHAIW vs TMDX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, TMDX has a market cap of 2.5B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while TMDX trades at $72.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas TMDX's P/E ratio is 36.75. In terms of profitability, DHAIW's ROE is +0.25%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, DHAIW is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check TMDX's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
DHAIW vs UFPT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while UFPT trades at $290.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas UFPT's P/E ratio is 29.63. In terms of profitability, DHAIW's ROE is +0.25%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, DHAIW is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check UFPT's competition here
AxoGen, Inc. (NASDAQ: AXGN)
DHAIW vs AXGN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while AXGN trades at $36.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas AXGN's P/E ratio is 96.00. In terms of profitability, DHAIW's ROE is +0.25%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, DHAIW is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
DHAIW vs NUVA Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NUVA's P/E ratio is 75.00. In terms of profitability, DHAIW's ROE is +0.25%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, DHAIW is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
DHAIW vs INSP Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while INSP trades at $71.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas INSP's P/E ratio is 31.30. In terms of profitability, DHAIW's ROE is +0.25%, compared to INSP's ROE of +0.18%. Regarding short-term risk, DHAIW is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
DHAIW vs BFLY Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BFLY trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BFLY's P/E ratio is -29.58. In terms of profitability, DHAIW's ROE is +0.25%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, DHAIW is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
DHAIW vs ESTA Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ESTA trades at $62.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ESTA's P/E ratio is -49.43. In terms of profitability, DHAIW's ROE is +0.25%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, DHAIW is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
DHAIW vs NVCR Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NVCR trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NVCR's P/E ratio is -11.99. In terms of profitability, DHAIW's ROE is +0.25%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, DHAIW is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
DHAIW vs ATEC Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ATEC has a market cap of 1.7B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ATEC trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ATEC's P/E ratio is -181.00. In terms of profitability, DHAIW's ROE is +0.25%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, DHAIW is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
DHAIW vs CNMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CNMD trades at $47.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CNMD's P/E ratio is 10.36. In terms of profitability, DHAIW's ROE is +0.25%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, DHAIW is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
DHAIW vs HSKA Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas HSKA's P/E ratio is -62.49. In terms of profitability, DHAIW's ROE is +0.25%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, DHAIW is similarly volatile compared to HSKA. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check HSKA's competition here
Enovis Corporation (NYSE: ENOV)
DHAIW vs ENOV Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ENOV has a market cap of 1.2B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ENOV trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ENOV's P/E ratio is 5.96. In terms of profitability, DHAIW's ROE is +0.25%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, DHAIW is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ENOV's competition here
Avanos Medical, Inc. (NYSE: AVNS)
DHAIW vs AVNS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas AVNS's P/E ratio is 27.77. In terms of profitability, DHAIW's ROE is +0.25%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, DHAIW is less volatile compared to AVNS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
DHAIW vs TNDM Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while TNDM trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas TNDM's P/E ratio is -17.58. In terms of profitability, DHAIW's ROE is +0.25%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, DHAIW is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check TNDM's competition here
IRadimed Corporation (NASDAQ: IRMD)
DHAIW vs IRMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while IRMD trades at $87.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas IRMD's P/E ratio is 44.13. In terms of profitability, DHAIW's ROE is +0.25%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, DHAIW is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check IRMD's competition here
Artivion, Inc. (NYSE: AORT)
DHAIW vs AORT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while AORT trades at $22.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas AORT's P/E ratio is 38.20. In terms of profitability, DHAIW's ROE is +0.25%, compared to AORT's ROE of -0.01%. Regarding short-term risk, DHAIW is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check AORT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
DHAIW vs SILK Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SILK's P/E ratio is -18.96. In terms of profitability, DHAIW's ROE is +0.25%, compared to SILK's ROE of -0.35%. Regarding short-term risk, DHAIW is less volatile compared to SILK. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
DHAIW vs FNA Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas FNA's P/E ratio is -19.83. In terms of profitability, DHAIW's ROE is +0.25%, compared to FNA's ROE of -0.35%. Regarding short-term risk, DHAIW is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check FNA's competition here
CeriBell, Inc. (NASDAQ: CBLL)
DHAIW vs CBLL Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CBLL trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CBLL's P/E ratio is -15.42. In terms of profitability, DHAIW's ROE is +0.25%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, DHAIW is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CBLL's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
DHAIW vs PRCT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PRCT trades at $18.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PRCT's P/E ratio is -9.42. In terms of profitability, DHAIW's ROE is +0.25%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, DHAIW is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
DHAIW vs LMRI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, LMRI has a market cap of 1B. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while LMRI trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas LMRI's P/E ratio is -21.03. In terms of profitability, DHAIW's ROE is +0.25%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, DHAIW is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check LMRI's competition here
Picard Medical, Inc. (AMEX: PMI)
DHAIW vs PMI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PMI has a market cap of 989M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PMI trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PMI's P/E ratio is -8.02. In terms of profitability, DHAIW's ROE is +0.25%, compared to PMI's ROE of -9.31%. Regarding short-term risk, DHAIW is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PMI's competition here
Bioventus Inc. (NASDAQ: BVS)
DHAIW vs BVS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BVS has a market cap of 972.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BVS trades at $14.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BVS's P/E ratio is 18.74. In terms of profitability, DHAIW's ROE is +0.25%, compared to BVS's ROE of +0.28%. Regarding short-term risk, DHAIW is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BVS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
DHAIW vs SIBN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SIBN has a market cap of 933.1M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SIBN trades at $20.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SIBN's P/E ratio is -61.24. In terms of profitability, DHAIW's ROE is +0.25%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, DHAIW is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
DHAIW vs IART Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, IART has a market cap of 920.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while IART trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas IART's P/E ratio is 5.02. In terms of profitability, DHAIW's ROE is +0.25%, compared to IART's ROE of +0.02%. Regarding short-term risk, DHAIW is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check IART's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
DHAIW vs CSII Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CSII has a market cap of 844M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CSII's P/E ratio is -20.83. In terms of profitability, DHAIW's ROE is +0.25%, compared to CSII's ROE of -0.14%. Regarding short-term risk, DHAIW is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CSII's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
DHAIW vs AHCO Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, AHCO has a market cap of 831.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while AHCO trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas AHCO's P/E ratio is 12.45. In terms of profitability, DHAIW's ROE is +0.25%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, DHAIW is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check AHCO's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
DHAIW vs BBNX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BBNX has a market cap of 827.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BBNX trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BBNX's P/E ratio is -11.15. In terms of profitability, DHAIW's ROE is +0.25%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, DHAIW is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
DHAIW vs INMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, INMD has a market cap of 807.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while INMD trades at $14.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas INMD's P/E ratio is 9.74. In terms of profitability, DHAIW's ROE is +0.25%, compared to INMD's ROE of +0.12%. Regarding short-term risk, DHAIW is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
DHAIW vs VREX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, VREX has a market cap of 782.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while VREX trades at $18.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas VREX's P/E ratio is 19.39. In terms of profitability, DHAIW's ROE is +0.25%, compared to VREX's ROE of +0.05%. Regarding short-term risk, DHAIW is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check VREX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
DHAIW vs CTKB Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CTKB has a market cap of 714.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CTKB trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CTKB's P/E ratio is -29.14. In terms of profitability, DHAIW's ROE is +0.25%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, DHAIW is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CTKB's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
DHAIW vs PACB Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PACB has a market cap of 665.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PACB trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PACB's P/E ratio is -5.22. In terms of profitability, DHAIW's ROE is +0.25%, compared to PACB's ROE of -49.62%. Regarding short-term risk, DHAIW is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PACB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
DHAIW vs KIDS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, KIDS has a market cap of 622.5M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while KIDS trades at $23.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas KIDS's P/E ratio is -20.20. In terms of profitability, DHAIW's ROE is +0.25%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, DHAIW is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check KIDS's competition here
Surmodics, Inc. (NASDAQ: SRDX)
DHAIW vs SRDX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SRDX's P/E ratio is -34.66. In terms of profitability, DHAIW's ROE is +0.25%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, DHAIW is similarly volatile compared to SRDX. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check SRDX's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
DHAIW vs AVR Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, AVR has a market cap of 585.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while AVR trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas AVR's P/E ratio is -3.10. In terms of profitability, DHAIW's ROE is +0.25%, compared to AVR's ROE of -0.78%. Regarding short-term risk, DHAIW is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check AVR's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
DHAIW vs APEN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas APEN's P/E ratio is -9.43. In terms of profitability, DHAIW's ROE is +0.25%, compared to APEN's ROE of -0.85%. Regarding short-term risk, DHAIW is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check APEN's competition here
ZimVie Inc. (NASDAQ: ZIMV)
DHAIW vs ZIMV Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, DHAIW's ROE is +0.25%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, DHAIW is similarly volatile compared to ZIMV. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
DHAIW vs TCMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, TCMD has a market cap of 527.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while TCMD trades at $23.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas TCMD's P/E ratio is 21.56. In terms of profitability, DHAIW's ROE is +0.25%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, DHAIW is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check TCMD's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
DHAIW vs DCTH Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, DCTH has a market cap of 510.1M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while DCTH trades at $14.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas DCTH's P/E ratio is 1470.00. In terms of profitability, DHAIW's ROE is +0.25%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, DHAIW is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check DCTH's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
DHAIW vs SSII Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SSII has a market cap of 483.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SSII trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SSII's P/E ratio is -40.17. In terms of profitability, DHAIW's ROE is +0.25%, compared to SSII's ROE of -0.27%. Regarding short-term risk, DHAIW is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SSII's competition here
Cerus Corporation (NASDAQ: CERS)
DHAIW vs CERS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CERS has a market cap of 481.6M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CERS trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CERS's P/E ratio is -79.40. In terms of profitability, DHAIW's ROE is +0.25%, compared to CERS's ROE of -0.10%. Regarding short-term risk, DHAIW is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CERS's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
DHAIW vs SGHT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SGHT has a market cap of 479.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SGHT trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SGHT's P/E ratio is -15.54. In terms of profitability, DHAIW's ROE is +0.25%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, DHAIW is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SGHT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
DHAIW vs NPCE Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NPCE has a market cap of 447.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NPCE trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NPCE's P/E ratio is -22.89. In terms of profitability, DHAIW's ROE is +0.25%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, DHAIW is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
DHAIW vs SENS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SENS has a market cap of 434.1M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SENS trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SENS's P/E ratio is -3.68. In terms of profitability, DHAIW's ROE is +0.25%, compared to SENS's ROE of -1.66%. Regarding short-term risk, DHAIW is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
DHAIW vs OFIX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, OFIX has a market cap of 393.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while OFIX trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas OFIX's P/E ratio is -6.34. In terms of profitability, DHAIW's ROE is +0.25%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, DHAIW is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check OFIX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
DHAIW vs RCEL Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, RCEL has a market cap of 379.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while RCEL trades at $15.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas RCEL's P/E ratio is -10.62. In terms of profitability, DHAIW's ROE is +0.25%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, DHAIW is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check RCEL's competition here
CapsoVision, Inc. (NASDAQ: CV)
DHAIW vs CV Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CV has a market cap of 361.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CV trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CV's P/E ratio is -10.79. In terms of profitability, DHAIW's ROE is +0.25%, compared to CV's ROE of -1.78%. Regarding short-term risk, DHAIW is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
DHAIW vs SMLR Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas SMLR's P/E ratio is 3.92. In terms of profitability, DHAIW's ROE is +0.25%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, DHAIW is similarly volatile compared to SMLR. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
DHAIW vs CLPT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CLPT has a market cap of 282.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CLPT trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CLPT's P/E ratio is -7.84. In terms of profitability, DHAIW's ROE is +0.25%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, DHAIW is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
DHAIW vs INFU Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, INFU has a market cap of 279.4M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while INFU trades at $14.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas INFU's P/E ratio is 34.22. In terms of profitability, DHAIW's ROE is +0.25%, compared to INFU's ROE of +0.15%. Regarding short-term risk, DHAIW is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check INFU's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
DHAIW vs TMCI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, TMCI has a market cap of 269.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while TMCI trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas TMCI's P/E ratio is -4.40. In terms of profitability, DHAIW's ROE is +0.25%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, DHAIW is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
DHAIW vs CATX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, CATX has a market cap of 261.4M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while CATX trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas CATX's P/E ratio is -1.72. In terms of profitability, DHAIW's ROE is +0.25%, compared to CATX's ROE of -0.42%. Regarding short-term risk, DHAIW is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check CATX's competition here
Quantum-Si incorporated (NASDAQ: QSI)
DHAIW vs QSI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, QSI has a market cap of 244.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while QSI trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas QSI's P/E ratio is -2.67. In terms of profitability, DHAIW's ROE is +0.25%, compared to QSI's ROE of -0.47%. Regarding short-term risk, DHAIW is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check QSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
DHAIW vs MGRM Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas MGRM's P/E ratio is -12.00. In terms of profitability, DHAIW's ROE is +0.25%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, DHAIW is similarly volatile compared to MGRM. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
DHAIW vs ELMD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ELMD has a market cap of 226.7M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ELMD trades at $27.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ELMD's P/E ratio is 20.89. In terms of profitability, DHAIW's ROE is +0.25%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, DHAIW is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
DHAIW vs TLSI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, TLSI has a market cap of 226M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while TLSI trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas TLSI's P/E ratio is -2.18. In terms of profitability, DHAIW's ROE is +0.25%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, DHAIW is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check TLSI's competition here
Nevro Corp. (NYSE: NVRO)
DHAIW vs NVRO Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas NVRO's P/E ratio is -1.91. In terms of profitability, DHAIW's ROE is +0.25%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, DHAIW is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
DHAIW vs PROF Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, PROF has a market cap of 207.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while PROF trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas PROF's P/E ratio is -5.81. In terms of profitability, DHAIW's ROE is +0.25%, compared to PROF's ROE of -0.56%. Regarding short-term risk, DHAIW is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
DHAIW vs RXST Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, RXST has a market cap of 203.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while RXST trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas RXST's P/E ratio is -4.34. In terms of profitability, DHAIW's ROE is +0.25%, compared to RXST's ROE of -0.17%. Regarding short-term risk, DHAIW is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
DHAIW vs BSGM Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas BSGM's P/E ratio is -5.81. In terms of profitability, DHAIW's ROE is +0.25%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, DHAIW is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
DHAIW vs MDGS Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas MDGS's P/E ratio is -0.27. In terms of profitability, DHAIW's ROE is +0.25%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, DHAIW is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check MDGS's competition here
Inogen, Inc. (NASDAQ: INGN)
DHAIW vs INGN Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, INGN has a market cap of 177M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while INGN trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas INGN's P/E ratio is -7.33. In terms of profitability, DHAIW's ROE is +0.25%, compared to INGN's ROE of -0.13%. Regarding short-term risk, DHAIW is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check INGN's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
DHAIW vs FOCL Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, FOCL has a market cap of 163.8M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while FOCL trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas FOCL's P/E ratio is -4.22. In terms of profitability, DHAIW's ROE is +0.25%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, DHAIW is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
DHAIW vs QIPT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas QIPT's P/E ratio is -15.87. In terms of profitability, DHAIW's ROE is +0.25%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, DHAIW is similarly volatile compared to QIPT. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check QIPT's competition here
Neuronetics, Inc. (NASDAQ: STIM)
DHAIW vs STIM Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, STIM has a market cap of 153.2M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while STIM trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas STIM's P/E ratio is -4.57. In terms of profitability, DHAIW's ROE is +0.25%, compared to STIM's ROE of -1.51%. Regarding short-term risk, DHAIW is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check STIM's competition here
Quanterix Corporation (NASDAQ: QTRX)
DHAIW vs QTRX Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, QTRX has a market cap of 131.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while QTRX trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas QTRX's P/E ratio is -1.10. In terms of profitability, DHAIW's ROE is +0.25%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, DHAIW is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
DHAIW vs OWLT Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, OWLT has a market cap of 122.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while OWLT trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas OWLT's P/E ratio is -30.04. In terms of profitability, DHAIW's ROE is +0.25%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, DHAIW is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
DHAIW vs ICAD Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ICAD's P/E ratio is -20.37. In terms of profitability, DHAIW's ROE is +0.25%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, DHAIW is similarly volatile compared to ICAD. This indicates similar risk in terms of short-term price fluctuations for DHAIW.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
DHAIW vs HJLI Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas HJLI's P/E ratio is N/A. In terms of profitability, DHAIW's ROE is +0.25%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, DHAIW is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
DHAIW vs ASXC Comparison October 2026
DIH Holding US, Inc. Warrants (NASDAQ: DHAIW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHAIW stands at 21.1K. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, DHAIW is priced at $0.01 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHAIW currently has a P/E ratio of N/A, whereas ASXC's P/E ratio is -1.12. In terms of profitability, DHAIW's ROE is +0.25%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, DHAIW is less volatile compared to ASXC. This indicates lower risk in terms of short-term price fluctuations for DHAIW.Check ASXC's competition here